Language selection

Search

2014-11-07 - Male - 24 Years old

631150

Adverse reaction report number 631150
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2014-11-07
Latest received date 2014-11-07
Age 24 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report Community
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting Yes
Hospitalization
Other medically important

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral10 Milligram1 every 1 Day(s) Product used for unknown indication
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral20 Milligram1 every 1 Day(s) Product used for unknown indication
CIPRALEXTABLETSuspectOral40 Milligram1 every 1 Day(s)2 Year(s)Product used for unknown indication
DANTRIUMCAPSULESuspectOral2 Dosage formsAs required Product used for unknown indication
TEMAZEPAMCAPSULESuspectOral15 Milligram1 every 1 Day(s) Product used for unknown indication

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Cardiomyopathy
Date modified: